RheumMadness   

This question is part of a collaboration with RheumMadness and is specifically in reference to: CD-19 CAR-T Cells

Do you have thoughts in general about the potential of TYK2 inhibition for these difficult to treat diseases?This question is part of a collaboration ...

This question is part of a collaboration with RheumMadness and is specifically in reference to: Cost Effectiveness of HCQ Screening.

What key factors will you consider when selecting patients for this therapy?This question is part of a collaboration with RheumMadness and i...

This question is part of a collaboration with RheumMadness and is specifically in reference to: Obinutuzumab in Lupus Nephritis

This question is part of a collaboration with RheumMadness and is specifically in reference to: Steroid Dose in Lupus Nephritis

This question is part of a collaboration with RheumMadness and is specifically in reference to: Long-term outcomes of anifrolumab in SLE.

X-rays without inflammatory changes. RF >120, CCP >250.This question is part of a collaboration with RheumMadness and is specifically in referen...

This question is part of a collaboration with RheumMadness and is specifically in reference to: CD40L inhibitor for Sjogren's

This question is part of a collaboration with RheumMadness and is specifically in reference to: CD40L inhibitor for Sjogren's

This question is part of a collaboration with RheumMadness and is specifically in reference to: Bissonnette et al., PMID 38324484

This question is part of a collaboration with RheumMadness and is specifically in reference to: ULT During Gout Flare.

When a PCP calls with concern for GCA and is wondering whether to start empiric steroids what data do you prioritize to make that decision and do you ...

This question is part of a collaboration with RheumMadness and is specifically in reference to: NORD-STAR (Østergaard et al., PMID 3742364...

Do you frequently order liver biopsies for these patients?This question is part of a collaboration with RheumMadness and is specifically in reference ...

This question is part of a collaboration with RheumMadness and is specifically in reference to: Prevention of Autoimmune Disease: Vitamin D and O...

This question is part of a collaboration with RheumMadness and is specifically in reference to: Allopurinol vs. Febuxostat

Do you plan to use sarilumab for all patients with relapsing or refractory PMR or are there certain features that will make you more or less likely to...

Will you still favor starting with steroids and traditional immunosuppressive agents, move IVIG earlier in your treatment strategy, or start with IVIG...

Do you advocate to taper the TNF-i or simply continue to monitor for long term adverse events? This question is part of a collaboration with Rheu...

What disease activity index do you find more useful and most practical in a busy clinical setting? How often do you assess it?This question is part of...

This question is part of a collaboration with RheumMadness and is specifically in reference to: Exercise in Knee OA

This question is part of a collaboration with RheumMadness and is specifically in reference to: Antibodies Before SLE.

This question is part of a collaboration with RheumMadness and is in reference to Pathogenic ANCA (RAVE Trial).

This question is part of a collaboration with RheumMadness and is specifically in reference to: Etanercept + Methotrexate.

This question is part of a collaboration with RheumMadness and is specifically in reference to: STRAP Trial: Biopsy Guided Treatment for RA

Do you prefer to start with nintedanib and then add immunosuppressive agents, or give a trial of immunosuppressive medication first, then add nintedan...

This question is part of a collaboration with RheumMadness and is specifically in reference to: Hydroxychloroquine Withdrawal.

This question is part of a collaboration with RheumMadness and is specifically in reference to:BeSt TrialMeasurement of Patient Outcomes in Arthritis

This question is part of a collaboration with RheumMadness and is specifically in reference to: EMBRACE

For example, would it be appropriate to consider JAK inhibitor therapy as preferable to TNF-alpha inhibitor in patients with heart failure with reduce...

This question is part of a collaboration with RheumMadness and is specifically in reference to: ADIRA Diet